No insider purchase over the last 90 days. The latest, by Giffoni Kim, was filed 24 Nov 2014.
This page follows insider dealings at Targeted Medical Pharma, Inc. as filed with SEC (Form 4), a company from the Health Care sector. Nothing new has been filed by managers of Targeted Medical Pharma, Inc. in twelve months, the latest record being from 8 March 2016.
Looking back to 2008, when coverage begins, insiders filed 84 purchases and 15 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2015 · cache
25 of 168 declarations
Targeted Medical Pharma, Inc. is a company focused on developing targeted medical treatments. It is listed on the XNAS market.